Comments
Loading...

Immix Biopharma

IMMXNASDAQ
$2.08
00.00%
Pre-Market: 7:00 AM EDT
15 minutes delayed

Immix Biopharma (NASDAQ:IMMX) Stock, Earnings Estimates, EPS, And Revenue

Immix Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 9
EPS Estimate
$-0.210
Quarterly Revenue Estimate
Annual Revenue
(as of Mar 31)

Analyze the earnings history of Immix Biopharma using advanced sorting and filters.

Get Alert
IMMX
Immix Biopharma
-$0.24-$0.21$0.0008/09/2024Get Alert
IMMX
Immix Biopharma
-$0.18-$0.23-$0.224.35%$0.00$0.0005/09/2024Get Alert
IMMX
Immix Biopharma
-$0.27-$0.23-$0.24-4.35%$0.00$0.0003/29/2024Get Alert
IMMX
Immix Biopharma
-$0.11-$0.23-$0.230.00%$0.00$0.0011/13/2023Get Alert
IMMX
Immix Biopharma
-$0.11-$0.17-$0.24-41.18%$0.00$0.0008/11/2023Get Alert
IMMX
Immix Biopharma
-$0.10-$0.14-$0.18-28.57%$0.00$0.0005/12/2023Get Alert
IMMX
Immix Biopharma
-$0.22-$0.27-22.73%$0.0003/27/2023Get Alert
IMMX
Immix Biopharma
-$0.11$0.0011/09/2022Get Alert
IMMX
Immix Biopharma
-$0.06-$0.11$0.00$0.0008/12/2022Get Alert
IMMX
Immix Biopharma
-$0.30-$0.10$0.00$0.0005/13/2022Get Alert

Immix Biopharma (IMMX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-05-09$-0.22$-0.234.35 %
Dec 20232024-03-29$-0.24$-0.23-4.35 %
Sep 20232023-11-13$-0.23$-0.230.00 %
Jun 20232023-08-11$-0.24$-0.17-41.2 %

Immix Biopharma (IMMX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Immix Biopharma (NASDAQ:IMMX) reporting earnings?

A

Immix Biopharma (IMMX) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Immix Biopharma (NASDAQ:IMMX)?

A

The Actual EPS was $-0.22, which beat the estimate of $-0.23.

Q

What were Immix Biopharma’s (NASDAQ:IMMX) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch